Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Geneva Capital Management LLC

Geneva Capital Management LLC trimmed its position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 201,838 shares of the biotechnology company’s stock after selling 1,281 shares during the quarter. Geneva Capital Management LLC owned about 0.27% of Axon Enterprise worth $52,141,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. BKM Wealth Management LLC purchased a new position in Axon Enterprise in the fourth quarter worth approximately $32,000. Key Financial Inc increased its position in shares of Axon Enterprise by 367.6% during the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares during the last quarter. Lindbrook Capital LLC raised its holdings in Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock valued at $44,000 after buying an additional 52 shares during the period. Rakuten Securities Inc. acquired a new position in Axon Enterprise in the fourth quarter valued at about $48,000. Finally, GAMMA Investing LLC purchased a new position in Axon Enterprise during the fourth quarter worth about $83,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on AXON shares. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. The Goldman Sachs Group upped their price objective on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. JPMorgan Chase & Co. increased their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Finally, Craig Hallum boosted their price objective on shares of Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research report on Tuesday. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $333.08.

Get Our Latest Stock Report on AXON

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded down $2.77 during trading on Thursday, hitting $309.09. 699,189 shares of the company were exchanged, compared to its average volume of 479,508. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. The firm has a 50 day moving average price of $310.82 and a 200 day moving average price of $267.44. The stock has a market capitalization of $23.32 billion, a price-to-earnings ratio of 91.19 and a beta of 0.91. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings data on Monday, May 6th. The biotechnology company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.51 EPS. On average, equities analysts expect that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.